SCHEMBL4009067

SCHEMBL4009067

COc1ccccc1C1(O)CNCc2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.51
KMT2A Q03164 1/20 0.42
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
OPRL1 P41146 1/20 0.38
PDK2 Q15119 1/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA12 O43570 1/20 0.35
CA4 P22748 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
DRD2 P14416 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13960159 0.84 SIGMAR1 (0.40) SIGMAR1PDK2
SCHEMBL3993555 0.83 SIGMAR1 (0.39) SIGMAR1KMT2APDK2
SCHEMBL3925433 0.79 SIGMAR1 (0.36) SIGMAR1KMT2A
SCHEMBL3996992 0.78 TMEM97 (0.35) SIGMAR1PDK2
SCHEMBL6946652 0.76 SIGMAR1 (0.55) SIGMAR1KMT2ACHRM2CHRM4CHRM5
SCHEMBL4009975 0.76 HTR2A (0.35) KMT2ADRD2PNMT
SCHEMBL15093559 0.76 HTR2A (0.35) KMT2ADRD2PNMT
SCHEMBL15093376 0.76 HTR2A (0.35) KMT2ADRD2PNMT
Hydrochloric Acid SCHEMBL5900851 0.72 SIGMAR1 (0.68) SIGMAR1KMT2ACHRM2CHRM4CHRM5
SCHEMBL30368868 0.68 SIGMAR1 (1.00) SIGMAR1KMT2ACHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009005459-A1 PHENYL-1,2, 3,4-TETRAHYDROISOQUINOLINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF A PAIN DISORDER ASTRAZENECA AB (SE) 2009-01-08 WO disclosed